{"transactions":[{"id":2194609,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-04T16:43:37.000Z","date":"2022-08-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the total shares on August 2, 2023, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":0.99,"expiration_date":"2032-08-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-22-044435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919122044435/doc4.xml","form_type":"4"}},{"id":2417004,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Restricted Stock Units","published_at":"2022-02-02T16:42:05.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest as to 1/2 of the total number of shares underlying the award on each of February 1, 2023 and February 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; these securities either vest and settle or are canceled prior to the vesting date."}],"balance_after":55000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-22-006398","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919122006398/doc4.xml","form_type":"4"}},{"id":2613183,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T16:29:41.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the total shares on August 3, 2022, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":6.8,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-049941","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121049941/doc4.xml","form_type":"4"}},{"id":2664130,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-06-17T21:46:03.000Z","date":"2021-06-16","kind":"sale","acquired":false,"shares":600,"price":10.19,"value":6114.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1352489,"source":{"system":"sec-edgar","filing":"0001209191-21-041814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121041814/doc4.xml","form_type":"4"}},{"id":2672313,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-06-11T16:13:13.000Z","date":"2021-06-09","kind":"sale","acquired":false,"shares":650,"price":10.8246,"value":7035.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $10.81 and the highest price at which shares were sold was $11.00. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":1353089,"source":{"system":"sec-edgar","filing":"0001209191-21-039819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121039819/doc4.xml","form_type":"4"}},{"id":2676000,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-06-09T17:22:16.000Z","date":"2021-06-08","kind":"sale","acquired":false,"shares":600,"price":11,"value":6600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1353739,"source":{"system":"sec-edgar","filing":"0001209191-21-039223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121039223/doc4.xml","form_type":"4"}},{"id":2679564,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-06-07T17:07:10.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":600,"price":10,"value":6000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1354339,"source":{"system":"sec-edgar","filing":"0001209191-21-038696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121038696/doc4.xml","form_type":"4"}},{"id":2695588,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-05-26T19:37:45.000Z","date":"2021-05-26","kind":"sale","acquired":false,"shares":600,"price":10,"value":6000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1354939,"source":{"system":"sec-edgar","filing":"0001209191-21-036057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121036057/doc4.xml","form_type":"4"}},{"id":2701095,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-05-21T17:24:45.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":600,"price":10.63,"value":6378.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,377 shares of Common Stock acquired on May 14, 2021 pursuant to the Issuer's employee stock purchase plan."}],"balance_after":1355539,"source":{"system":"sec-edgar","filing":"0001209191-21-035020","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121035020/doc4.xml","form_type":"4"}},{"id":2716810,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-05-12T20:53:30.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":1200,"price":11.09,"value":13308.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1354762,"source":{"system":"sec-edgar","filing":"0001209191-21-032244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121032244/doc4.xml","form_type":"4"}},{"id":2725273,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-05-06T17:28:31.000Z","date":"2021-05-05","kind":"sale","acquired":false,"shares":1200,"price":11.3,"value":13560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1355962,"source":{"system":"sec-edgar","filing":"0001209191-21-030654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121030654/doc4.xml","form_type":"4"}},{"id":2734684,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-04-30T17:52:42.000Z","date":"2021-04-28","kind":"sale","acquired":false,"shares":2400,"price":12.58,"value":30192.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $12.44 and the highest price at which shares were sold was $13.00. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":1357162,"source":{"system":"sec-edgar","filing":"0001209191-21-029342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121029342/doc4.xml","form_type":"4"}},{"id":2738666,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-04-27T19:59:14.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":600,"price":13,"value":7800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1359562,"source":{"system":"sec-edgar","filing":"0001209191-21-028727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121028727/doc4.xml","form_type":"4"}},{"id":2742102,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-04-22T17:11:19.000Z","date":"2021-04-21","kind":"sale","acquired":false,"shares":1800,"price":11.98,"value":21564.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $11.97 and the highest price at which shares were sold was $12.00. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":1360162,"source":{"system":"sec-edgar","filing":"0001209191-21-027971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121027971/doc4.xml","form_type":"4"}},{"id":2747211,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-04-16T19:08:51.000Z","date":"2021-04-14","kind":"sale","acquired":false,"shares":1800,"price":12.22,"value":21996.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1361962,"source":{"system":"sec-edgar","filing":"0001209191-21-027050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121027050/doc4.xml","form_type":"4"}},{"id":2753182,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-04-08T19:06:00.000Z","date":"2021-04-07","kind":"sale","acquired":false,"shares":1800,"price":12.02,"value":21636.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1363762,"source":{"system":"sec-edgar","filing":"0001209191-21-026153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121026153/doc4.xml","form_type":"4"}},{"id":2755933,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-04-06T20:37:24.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":600,"price":13,"value":7800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1365562,"source":{"system":"sec-edgar","filing":"0001209191-21-025767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121025767/doc4.xml","form_type":"4"}},{"id":2761741,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-04-02T17:21:06.000Z","date":"2021-03-31","kind":"sale","acquired":false,"shares":1800,"price":11.96,"value":21528.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $11.94 and the highest price at which shares were sold was $12.00. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":1366162,"source":{"system":"sec-edgar","filing":"0001209191-21-024707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121024707/doc4.xml","form_type":"4"}},{"id":2773342,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-03-24T18:48:03.000Z","date":"2021-03-24","kind":"sale","acquired":false,"shares":1800,"price":11.9533,"value":21515.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $11.93 and the highest price at which shares were sold was $12.00. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":1367962,"source":{"system":"sec-edgar","filing":"0001209191-21-022929","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121022929/doc4.xml","form_type":"4"}},{"id":2773341,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-03-24T18:48:03.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":600,"price":12,"value":7200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1369762,"source":{"system":"sec-edgar","filing":"0001209191-21-022929","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121022929/doc4.xml","form_type":"4"}},{"id":2779585,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-03-18T20:45:56.000Z","date":"2021-03-17","kind":"sale","acquired":false,"shares":1200,"price":11.36,"value":13632.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1370362,"source":{"system":"sec-edgar","filing":"0001209191-21-021946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121021946/doc4.xml","form_type":"4"}},{"id":2794906,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-03-11T16:14:37.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":1800,"price":11.9667,"value":21540.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $11.95 and the highest price at which shares were sold was $12.00. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":1371562,"source":{"system":"sec-edgar","filing":"0001209191-21-019776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121019776/doc4.xml","form_type":"4"}},{"id":2809201,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-03-04T18:52:59.000Z","date":"2021-03-03","kind":"sale","acquired":false,"shares":1800,"price":11.8667,"value":21360.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $11.80 and the highest price at which shares were sold was $12.00. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":1373362,"source":{"system":"sec-edgar","filing":"0001209191-21-017994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121017994/doc4.xml","form_type":"4"}},{"id":2833152,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-02-25T20:17:11.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":600,"price":13,"value":7800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1375162,"source":{"system":"sec-edgar","filing":"0001209191-21-014513","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121014513/doc4.xml","form_type":"4"}},{"id":2833151,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-02-25T20:17:11.000Z","date":"2021-02-24","kind":"sale","acquired":false,"shares":1800,"price":12.14,"value":21852.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1375762,"source":{"system":"sec-edgar","filing":"0001209191-21-014513","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121014513/doc4.xml","form_type":"4"}},{"id":2850822,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-02-18T16:20:32.000Z","date":"2021-02-17","kind":"sale","acquired":false,"shares":2400,"price":12.7,"value":30480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $12.62 and the highest price at which shares were sold was $13.00. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein."}],"balance_after":1377562,"source":{"system":"sec-edgar","filing":"0001209191-21-011834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121011834/doc4.xml","form_type":"4"}},{"id":2863854,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-02-12T16:23:27.000Z","date":"2021-02-10","kind":"sale","acquired":false,"shares":3000,"price":14.2,"value":42600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1379962,"source":{"system":"sec-edgar","filing":"0001209191-21-010148","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121010148/doc4.xml","form_type":"4"}},{"id":2872401,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-02-09T16:41:34.000Z","date":"2021-02-05","kind":"sale","acquired":false,"shares":600,"price":14,"value":8400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1382962,"source":{"system":"sec-edgar","filing":"0001209191-21-008839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121008839/doc4.xml","form_type":"4"}},{"id":2876909,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-02-05T16:51:16.000Z","date":"2021-02-03","kind":"sale","acquired":false,"shares":2400,"price":13.23,"value":31752.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."}],"balance_after":1383562,"source":{"system":"sec-edgar","filing":"0001209191-21-008129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121008129/doc4.xml","form_type":"4"}},{"id":2886192,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":124903,"kind":"person","name":"Walkey Carl","position":1,"cik":"0001843189","reported_name":"Walkey Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-02T16:11:57.000Z","date":"2021-01-30","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the total shares on January 30, 2022, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":45000,"derivative":{"exercise_price":12.6,"expiration_date":"2031-01-30","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-21-006730","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843189/000120919121006730/doc4.xml","form_type":"4"}}]}